ACR/ARHP Poster Session C 2027. Inflammatory Aortitis: Diagnostic Performance <strong>of</strong> Aorta Wall Thickness CT-scan Measuring. Maia Forgues 8 , Jacques Giron 12 , Anne Hitzel 11 , Anne Julian 11 , Pierre Payoux 11 , Daniel Adoue 10 , Frédéric Degraeve 2 , Serge Madaule 1 , Laurent Prudhomme 3 , Yann Leveneur 4 , Francis Gaches 6 , Xavier Delbrel 5 , Leonardo Astudillo 9 , Bruno Marchou 7 , Philippe Arlet 10 and Laurent Sailler 8 , 1 CHG, Albi, France, 2 CHG, Auch, France, 3 CHG, Castres, France, 4 CHG, Lannemezan, France, 5 CHG, Pau, France, 6 Hôpital J Ducuing, Toulouse, France, 7 Hôpital Purpan, Infectious Diseases Department, Université de Toulouse, 8 Hôpital Purpan, Internal Medicine Department, Université de Toulouse, Toulouse, France, 9 Hôpital Purpan, Internal Medicine Department, Université de Toulouse, Toulouse, 10 Hôpital Purpan, Internal Medicine Department, Université de Toulouse, 11 Hôpital Purpan, Nuclear Medicine Department, Université de Toulouse, 12 Hôpital Purpan, Radiology Department, Université de Toulouse. 2028. Interleukin-32 and Its Autoantibody Are Elevated in Patients with Wegener’s Granulomatosis and Correlated with Treatment Response. Suyoung Bae 3 , Yong-Gil Kim 2 , Siyoung Lee 4 , MinWook So 2 , Chang-Keun Lee 2 , Bin Yoo 1 , Yong-Beom Park 5 and Soohyun Kim 3 , 1 ASAN Medical Ctr, Seoul, Korea, Republic <strong>of</strong>, 2 ASAN Medical Ctr, 3 Konkuk University, Seoul, Korea, Republic <strong>of</strong>, 4 Konkuk University, 5 Yonsei University. 2029. Investigation <strong>of</strong> the Effect <strong>of</strong> Histone Deacetylase 2 Function on Wegener’s Granulomatosis. Dai Takagi 1 , Yuji Nakamaru 2 , Shigeru Akazawa 2 and Satoshi Fukuda 2 , 1 Department <strong>of</strong> Otolaryngology and Head &Neck Surgery Hokkaido University Graduate School <strong>of</strong> Medicine, Sapporo, Hokkaido, Japan, 2 Department <strong>of</strong> Otolaryngology and Head &Neck Surgery Hokkaido University Graduate School <strong>of</strong> Medicine. 2030. Low 25-OH Vitamin D Serum Levels Correlate with Extra- Hepatic Manifestations in Chronic Hepatitis C Virus Infection. Benjamin Terrier 2 , Jean-Claude Souberbielle 1 , David Saadoun 3 , Guillaume Geri 3 , Yoland Schoindre 3 , Damien Sène 3 , Lucile Musset 3 and Patrice Cacoub 4 , 1 Necker, 2 Pitié-Salpéterière, Paris, France, 3 Pitié-Salpéterière, 4 Pitié-Salpétrière. 2031. Patulous Eustachian Tube: A Novel Form <strong>of</strong> Damage in Wegener’s Granulomatosis. Philip Seo 1 and Howard W. Francis 2 , 1 Johns Hopkins Bayview Medical Center, Baltimore, MD, 2 Johns Hopkins University. 2032. Phase 1 Clinical Safety, Pharmacokinetic and Pharmacodynamic Evaluation <strong>of</strong> the Novel C5aR Antagonist CCX168, a Potential Therapeutic for ANCA-Vasculitis. Daniel J. Dairaghi, Juan C. Jaen, Kara Deshayes, Daniel A. Johnson, Manmohan R. Leleti, Shichang Miao, Jay P. Powers, Lisa C. Seitz, Yu Wang, Thomas J. Schall and Pirow J. Bekker, ChemoCentryx. 2033. Predictors <strong>of</strong> Outcome in Juvenile Polyarteritis Nodosa: A Multicenter Study. Fernanda Falcini 1 , Francesco La Torre 7 , Giorgia Martini 7 , Fabio Vittadello 7 , Antonella Boncompagni 10 , Fabrizia Corona 6 , Maria Alessio 3 , Elisabetta Cortis 2 , Silvia Magni-Manzoni 8 , Giuseppina Calcagno 5 , Luciana Breda 4 , Matilde Beltramelli 6 , Manuela Pardeo 9 , Serena Capannini 1 , Marco Matucci Cerinic 1 and Francesco Zulian 7 , 1 Dpt <strong>of</strong> BioMedicine, Division <strong>of</strong> <strong>Rheumatology</strong>, Transition Unit, University <strong>of</strong> Florence, 2 Dpt <strong>of</strong> Medicine, Division <strong>of</strong> <strong>Rheumatology</strong>, Ospedale Pediatrico, 3 Dpt <strong>of</strong> Pediatrics, <strong>Rheumatology</strong> Unit, Ospedale Federico II, 4 Dpt <strong>of</strong> Pediatrics, University <strong>of</strong> Chieti, Chieti, 5 Dpt <strong>of</strong> Pediatrics, University <strong>of</strong> Messina, 6 Dpt <strong>of</strong> Pediatrics, University <strong>of</strong> Milan, 7 Dpt <strong>of</strong> Pediatrics, University <strong>of</strong> Padua, 8 San Matteo Hospital, Pavia, 9 Scientific Institute Bambino Gesu, Rome, 10 Scientific Institute G. Gaslini, Genoa. 2034. Pregnancies in Systemic Necrotizing Vasculitides: Report on 12 Women and Their 20 Pregnancies. Christian Pagnoux 3 , Véronique Le Guern, François G<strong>of</strong>finet 1 , Elisabeth Diot, Nicolas Limal, Emmanuelle Pannier, Ursula Warzocha, Vassilis Tsatsaris, Robin Dhote, Alexandre Karras, Pascal Cohen, Richard Damade, Luc Mouthon and Loic P. Guillevin 2 , 1 Gynecology and Obstetrics, 2 Hopital Cochin-Paris Univ, Paris, France, 3 Hopital Cochin-Paris Universite Descartes, APHP, Paris, France. 2035. Pregnancy Related Morbidity and Mortality in Patients with Systemic Vasculitis – A Single Centre Controlled Study. Shirish R. Sangle 1 , Periklis Vounotrypidis 2 , Ahlem Chaib 2 , Veronica Salas-Manzanedo 2 , Annette I. Briley 1 , Simon Angel 1 , Andrew Shennan 1 , Munther A. Khamashta 1 and David P. D’Cruz 1 , 1 St Thomas’ Hospital, London, United Kingdom, 2 St Thomas’ Hospital. 2036. Preliminary Classification Criteria for the Cryoglobulinemic Syndrome. Salvatore De Vita 18 , Franca Soldano 3 , Miriam Isola 3 , Giuseppe Monti 12 , Armando Gabrielli 14 , Athanasios Tzioufas 7 , Clodoveo Ferri 20 , Gianfranco Ferraccioli 19 , Luca Quartuccio 17 , Laura Corazza 17 , Ginevra De Marchi 17 , Manuel Ramos-Casals 16 , Michael Voulgarelis 5 , Marco Lenzi 4 , Francesco Saccardo 12 , Paolo Fraticelli 14 , Maria Teresa Mascia 20 , Domenico Sansonno 23 , Patrice Cacoub 2 , Matja Tomsic 8 , Antonio Tavoni 21 , Maurizio Pietrogrande 11 , Anna Linda Zignego 1 , Salvatore Scarpato 22 , Cesare Mazzaro 6 , Paolo Pioltelli 13 , Serge Steinfeld 9 , Peter Lamprecht 10 , Stefano Bombardieri 21 and Massimo Galli 15 , 1 Center for Systemic Manifestations <strong>of</strong> Hepatitis Viruses (MaSVE), Department <strong>of</strong> Internal Medicine, University <strong>of</strong> Florence, Florence, Italy, 2 Centre de Références Maladies Auto-Immunes, Service de Médecine Interne II, Hôpital Pitié-Salpêtrière, Paris, France, 3 Chair <strong>of</strong> Statistics, University <strong>of</strong> Udine, 4 Department <strong>of</strong> Clinical Medicine, University <strong>of</strong> Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy, 5 Department <strong>of</strong> Hematology, Medical School, University <strong>of</strong> Athens, Greece, 6 Department <strong>of</strong> Internal Medicine, Pordenone General Hospital, Pordenone, Italy, 7 Department <strong>of</strong> Pathophysiology, Medical School <strong>of</strong> Athens, Athens, Greece, 8 Department <strong>of</strong> <strong>Rheumatology</strong>, University Medical Centre, Ljubljana, Slovenia, 9 Erasme University Hospital, Department <strong>of</strong> <strong>Rheumatology</strong>, Brussels, Belgium, 10 Institute <strong>of</strong> Immunology, University <strong>of</strong> Kiel, Kiel, Germany, 11 Internal Medicine Unit, Policlinico San Marco, Bergamo, Italy, 12 Internal Medicine Unit, Saronno Hospital, Azienda Ospedaliera di Busto Arsizio, Saronno, VA, Italy, 13 Internal Medicine, Donizetti Hospital, Monza, Italy, 14 Internal Medicine, Università Politecnica delle Marche, Ancona, Italy, 15 Istituto di Malattie Infettive e Tropicali, Università di Milano c/o Ospedale L. Sacco, Milan, Italy, 16 Laboratorio de Enfermedades Autoinmunes Josep Font, IDIBAPS, Hospital Clínic, Barcelona, Spain, 17 <strong>Rheumatology</strong> Clinic, AOU SMM, University <strong>of</strong> Udine, 18 <strong>Rheumatology</strong> Clinic, AOU SMM, University <strong>of</strong> Udine, Udine, Italy, 19 <strong>Rheumatology</strong> Division, Catholic University <strong>of</strong> the Sacred Heart, School <strong>of</strong> Medicine, Rome, Italy, 20 <strong>Rheumatology</strong> Unit, Department <strong>of</strong> Internal Medicine, University <strong>of</strong> Modena, Italy, 21 <strong>Rheumatology</strong> Unit, Department <strong>of</strong> Internal Medicine, University <strong>of</strong> Pisa, Pisa, Italy, 22 <strong>Rheumatology</strong> Unit, M. Scarlato Hospital, Scafati, Salerno, Italy, 23 Section <strong>of</strong> Internal Medicine and Clinical Oncology, Department <strong>of</strong> Biomedical Sciences and Human Oncology, University <strong>of</strong> Bari, Medical School, Bari, Italy. 2037. Primary Central Nervous System Vasculitis Presenting with Intracranial Hemorrhage. Carlo Salvarani 1 , Robert D. Brown, Jr 3 , Kenneth T. Calamia 2 , Teresa J. H. Christianson 3 , John Huston III 3 , James F. Meschia 2 , Caterina Giannini 3 and Gene G. Hunder 3 , 1 Hospital <strong>of</strong> Reggio Emilia, Italy, 2 Mayo Clinic, Jacksonville, FL, 3 Mayo Clinic, Rochester, MN. 276 2010 Program Book
ACR/ARHP Poster Session C 2038. Primary Central Nervous System Vasculitis: Analysis <strong>of</strong> 131 Patients. Carlo Salvarani 1 , Robert D. Brown, Jr 3 , Kenneth T. Calamia 2 , Teresa J. H. Christianson 3 , John Huston III 3 , James F. Meschia 2 , Caterina Giannini 3 and Gene G. Hunder 3 , 1 Hospital <strong>of</strong> Reggio Emilia, Reggio Emilia, Italy, 2 Mayo Clinic, Jacksonville, FL, 3 Mayo Clinic, Rochester, MN. 2039. Prognostic Factors in Hepatitis C Virus Patients with Systemic Vasculitis. Benjamin Terrier 1 , Oren Semoun 2 , David Saadoun 1 , Damien Sène 1 , Matthieu Resche-Rigon 2 and Patrice Cacoub 1 , 1 Pitié-Salpéterière, 2 Saint-Louis. 2040. Risk Factors for Aortitis among Patients with Pathological Examination after Resection <strong>of</strong> the Thoracic Aorta in Denmark 1997-2009: A 12-Year Nationwide Population-Based Cross- Sectional Study. Jean Schmidt 1 , Kaare Sunesen 2 , Jette Kornum 2 , Pierre Duhaut 1 and Reimar Thomsen 2 , 1 Amiens University Hospital and RECIF, Amiens, France, 2 Department <strong>of</strong> Clinical Epidemiology, Aarhus University Hospital, Aalborg, Denmark. 2041. Rituximab Maintenance Therapy for Relapsed Wegener’s Granulomatosis and Microscopic Polyangiitis. Claire Roubaud- Baudron 3 , Christian Pagnoux 3 , Julien Le Guen 3 , Mathilde de Menthon 3 , Sandra Camps 1 , Jessie Aouizerate 3 , Véronique Le Guern 3 , Pascal Cohen 3 , Luc Mouthon 3 and Loic P. Guillevin 2 , 1 Department <strong>of</strong> Pharmacy, Hopital COchin, APHP, Universite Paris Descartes, 2 Hopital Cochin-Paris Univ, Paris, France, 3 Internal Medicine, Hopital Cochin, APHP, Universite Paris Descartes, France. 2042. Safety and Efficacy <strong>of</strong> Rituximab in Non-Viral Cryoglobulinemia Vasculitis: Prospective Data from the French AIR Registry. Benjamin Terrier 15 , David Launay 6 , Gilles Kaplanski 10 , Arnaud Hot 9 , Claire Larroche 1 , Pascal Cathebras 12 , Bernard Combe 11 , Jean-Pierre Jaureguiberry 14 , Olivier Meyer 3 , Thierry Schaeverbeke 8 , Alexandre Somogyi 5 , Leila Tricot 13 , Thierry Zenone 4 , Philippe Ravaud 3 , Jacques-Eric Gottenberg 7 , Xavier Mariette 2 and Patrice Cacoub 15 , 1 Avicenne, 2 Bicêtre, 3 Bichat, 4 CH Valence, 5 CHI Saint-Germain, 6 CHRU Lille, 7 CHRU Strasbourg, 8 CHU Bordeaux, 9 CHU LYon, 10 CHU Marseille, 11 CHU Montpellier, 12 CHU St Etienne, 13 CMC Foch, 14 HIA Toulon, 15 Pitié-Salpétrière. 2043. Seasonal- (SFV) and H1N1-Flu Virus (HFV) Vaccination for Patients with Autoimmune Diseases (AID): The Prospective MAIVAX Trial on 174 Patients. Alex Kostianovsky 2 , Michele Goulet 2 , Jean Francois Alves 2 , Veronique Le Guern 2 , Christian Pagnoux 2 , Pascal Cohen 2 , Alice Berezne 2 , Anne Krivine 2 , Luc Mouthon 2 , Odile Launay 2 and Loic P. Guillevin 1 , 1 Hopital Cochin- Paris Univ, Paris, France, 2 Internal Medicine, Hopital Cochin, APHP, Universite Paris Descartes, Paris, France. 2044. Small-Vessel Vasculitis Surrounding an Uninflamed Temporal Artery: A Population-Based Italian Study. Giovanna Restuccia, Luigi Boiardi, Alberto Cavazza, Luca Magnani, Maria Grazia Catanoso, Gianluigi Bajocchi, Fulvia Rossi, Pierluigi Macchioni, Ilaria Chiarolanza, Andrea Caruso, Nicolò Pipitone and Carlo Salvarani, Arcispedale S Maria Nuova, Reggio Emilia, Italy. 2045. |Systemic Necrotizing Vasculitides in the Elderly: Baseline Data on the 101 Patients >65 Years Old Enrolled in the CORTAGE Multicenter Trial. Christian Pagnoux 8 , Florence Rollot 9 , Thomas Quemeneur 7 , Jacques Ninet 4 , Elisabeth Diot 3 , Xavier Kyndt 7 , Benoît de Wazières 12 , Jean-Luc Reny 2 , Xavier J. Puechal 1 , Pierre-Yves Leberruyer 13 , Olivier Lidove 11 , Pascal Godmer 10 , Aimé Albath-Sadiki 14 , Severine Poignant 14 , Pascal Cohen 8 , Luc Mouthon 8 , Loic P. Guillevin 6 and The FVSG 5 , 1 Centre Hospitalier Du Mans, Le Mans, France, 2 CH Béziers - Narbonne, 3 CHRU TOurs, Medecine Interne, 4 CHU de Lyon - Hôpitale Edouard Herriot, Médecine Interne-Pathologie Vasculaire, 5 France, 6 Hopital Cochin-Paris Univ, Paris, France, 7 Internal Medicine, CH Valenciennes, 8 Internal Medicine, Hopital Cochin, APHP, Universite Paris Descartes, 9 Internal Medicine, Hopital Cochin, APHP, Universite Paris Descartes, 10 Medecine Interne, Centre Hospitalier Bretagne-Atlantique, BP 70555 56017 VANNES, 11 Medecine Interne, CHU Bichat, Paris Diderot, 12 Medecine Interne, CHU de Nimes, 13 Service de Medecine Interne. CHU Robert Debré. Avenue du Général Koenig. 51092 REIMS, 14 URC Cochin Tarnier, Paris Descartes. 2046. Systemic Vasculitis in Patients with Hepatitis C Virus Infection with and without Detectable Mixed Cryoglobulinemia: Towards a Unique Entity. Benjamin Terrier 1 , Damien Sène 1 , Agnès Dechartres 2 , David Saadoun 1 , Lucile Musset 1 , Matthieu Resche-Rigon 2 , Thierry Maisonobe 1 and Patrice Cacoub 1 , 1 Pitié- Salpéterière, 2 Saint-Louis. 2047. The Correlation between Circulating Microparticles and Platelet Aggregation and Disease Activity in Wegener Granulomatosis. Rula Hajj-Ali 3 , Roy Silverstein 1 , Gary H<strong>of</strong>fman 1 , Li Zhang 1 , Peter Imrey 1 and Carol A. Langford 2 , 1 Cleveland Clinic, 2 Cleveland Clinic Foundation, Cleveland, OH, 3 Clevelnad Clinic, Cleveland, OH. 2048. The Human C5a Receptor (hC5aR) Antagonist CCX168 Effectively Ameliorates a Model <strong>of</strong> ANCA Glomerulonephritis (GN) in hC5aR Knock-in Mice. Hong Xiao 2 , J. C. Jennette 3 , D. J. Dairaghi 1 , L. Ertl 1 , T. Baumgart 1 , S. Miao 1 , J. P. Powers 1 , L. C. Seitz 1 , Y. Wang 1 , P. Hu 3 , R. J. Falk 3 , T. J. Schall 1 and J. C. Jaen 1 , 1 ChemoCentryx, 2 University <strong>of</strong> North Carolina, Chapel Hill, NC, 3 University <strong>of</strong> North Carolina. 2049. The Relationship between Disease Status in Wegener’s Granulomatosis with the Development <strong>of</strong> Subclinical Atherosclerosis. Rula Hajj-Ali 5 , Roy Silverstein 2 , Douglas Joseph 1 , Peter Imrey 2 , Gary S. H<strong>of</strong>fman 4 , Li Zhang 2 and Carol A. Langford 3 , 1 Cleevland Clinic, 2 Cleveland Clinic, 3 Cleveland Clinic Foundation, Cleveland, OH, 4 Cleveland Clinic Foundation, Pepper Pike, OH, 5 Clevelnad Clinic, Cleveland, OH. Epidemiology and Health Services Research 2089. Increased Fracture Rates among Female Osteoporosis Patients Taking Oral Bisphosphonates and Proton Pump Inhibitors Concurrently. Neetu Agashivala 1 and Wing Chan 2 , 1 Novartis Pharmaceuctical Corp, East Hanover, NJ, 2 Novartis Pharmaceuctical Corp ARHP Poster Session C: Physical Exercise 2050. ‘Specialized Generalists’: How Do Rehabilitation Therapists Practice in Rural Areas? Robin K. Roots, Linda C. Li, Lesley Bainbridge and Helen Brown, University <strong>of</strong> British Columbia, Vancouver, BC, Canada. 2051. An Update <strong>of</strong> the Dutch Physical Therapy Guideline on Hip and Knee Osteoarthritis (HKOA). Wilfred F. H. Peter 5 , Mariette J. Jansen 1 , Emalie J. Hurkmans 6 , Hans Bloo 12 , Leatitia M. M. C. J. Dekker-Bakker 11 , Roelien G. Dilling 10 , Wim K. H. A. Hilberdink 10 , Clarinda Kersten-Smit 3 , Mariette de Rooij 8 , Cindy Veenh<strong>of</strong> 9 , Eric M. Vermeulen 2 , Ineke de Vos 7 , Jan W. Schoones 13 and Thea P. M. Vliet Vlieland 4 , 1 Centre for Evidence Based Physiotherapy (CEBP), University <strong>of</strong> Maastricht, Maastricht, The Netherlands, 2 Department <strong>of</strong> Physical Therapy, LUMC, Leiden, The Netherlands, 3 Department <strong>of</strong> Physical Therapy, St. Maartenskliniek, Nijmegen, The Netherlands, 4 Department <strong>of</strong> <strong>Rheumatology</strong>, Leiden University Medical Center (LUMC), 2010 Program Book 277
- Page 1 and 2:
program B O O K Pre-Conference Cour
- Page 3 and 4:
program B O O K ABOUT ACR/ARHP EDUC
- Page 5 and 6:
TABLE OF CONTENTS ACCREDITATION . .
- Page 7 and 8:
TABLE OF CONTENTS ACR/ARHP Poster S
- Page 9 and 10:
TABLE OF CONTENTS Systemic Sclerosi
- Page 11 and 12:
the written consent of the ACR is p
- Page 13 and 14:
Shuttle Bus Service See shuttle sig
- Page 15 and 16:
ACR Resource Center Hours: Sunday,
- Page 17 and 18:
ACR Hotels + Map Complimentary shut
- Page 19 and 20:
to the premier meeting in rheumatol
- Page 21 and 22:
ACR Clinical Research Conference c/
- Page 23 and 24:
4:20 PM Germinal Center Reactions A
- Page 25 and 26:
3:30 PM Live Demonstration: Ultraso
- Page 27 and 28:
Upon completion of this session, pa
- Page 29 and 30:
MONDAY, NOVEMBER 8, 2010 ACR/ARHP R
- Page 31 and 32:
B301 Dermatological Manifestations
- Page 33 and 34:
Session Overview: The innate immune
- Page 35 and 36:
Upon completion of this session, pa
- Page 37 and 38:
B308 Inflammatory Eye Disease P/C M
- Page 39 and 40:
and insufficiency • recall source
- Page 41 and 42:
Session Overview: The advent of bio
- Page 43 and 44:
2:45 pm 641. Major Improvements in
- Page 45 and 46:
5 University of Twente and Medisch
- Page 47 and 48:
ACR/ARHP Combined Abstract Session
- Page 49 and 50:
REF 25th Anniversary Celebration 2:
- Page 51 and 52:
5:45 PM 699. Defining Latent and/or
- Page 53 and 54:
Lilian H. D. van Tuyl 8 , Karin Bri
- Page 55 and 56:
ACR REF Special Sessions 4:30 - 6:0
- Page 57 and 58:
REF 5K Run/Walk 6:00 - 8:00 am See
- Page 59 and 60:
• discuss the principles of early
- Page 61 and 62:
ACR Medical Aspects of Rheumatic Di
- Page 63 and 64:
10:00 am 1349. Work as a Daily Chal
- Page 65 and 66:
ACR Plenary Session II: Discovery 2
- Page 67 and 68:
B210 B301 Pediatrics: Periodic Feve
- Page 69 and 70:
Session Overview: As a clinical edu
- Page 71 and 72:
Thomas J. Murphy Ballroom Giant Cel
- Page 73 and 74:
3:45 PM 1367. Serum Urate Levels in
- Page 75 and 76:
A411 Rheumatoid Arthritis - Human E
- Page 77 and 78:
2:45 PM 1405. Development of a Visi
- Page 79 and 80:
4:30 PM Anti-citrullinated Protein
- Page 81 and 82:
of Experimental Orthopedics, Univer
- Page 83 and 84:
5:30 PM 1438. Mortality/Morbidity i
- Page 85 and 86:
5:30 PM 1456. Belimumab, a BLyS-Spe
- Page 87 and 88:
Develly 5 , Bernardo L. F. Fernande
- Page 89 and 90:
7:30 PM Role of IL-1 in Human Artic
- Page 91 and 92:
• compare the prevalence and epid
- Page 93 and 94:
6:45 PM Macrophage Activation Syndr
- Page 95 and 96:
Upon completion of this session, pa
- Page 97 and 98:
Session Overview: This roundtable d
- Page 99 and 100:
B303 Scleroderma: Systemic Sclerosi
- Page 101 and 102:
9:00 - 10:30 am - Poster Hall Morni
- Page 103 and 104:
• describe the role of IL-1 and I
- Page 105 and 106:
Session Overview: For the clinician
- Page 107 and 108:
• identify the aspects for day-to
- Page 109 and 110:
ACR Study Groups 1:00 - 2:00 PM B30
- Page 111 and 112:
Session Overview: Ultrasound and ma
- Page 113 and 114:
Session Overview: Fifty percent of
- Page 115 and 116:
1:20 PM Academic Rheumatology Seth
- Page 117 and 118:
ACR Concurrent Abstract Sessions 2:
- Page 119 and 120:
3:00 PM 2110. Rheumatologists on th
- Page 121 and 122:
2:45 PM 2133. Reasons for Decline i
- Page 123 and 124:
Session Overview: We are witnessing
- Page 125 and 126:
Session Overview: Systemic sclerosi
- Page 127 and 128:
Oaks, CA, 2 Amgen Inc., San Francis
- Page 129 and 130:
5:00 PM 2176. A Role of Autoimmune
- Page 131 and 132:
4:30 PM 2198. Association between V
- Page 133 and 134:
ARHP Concurrent Sessions 4:30 - 6:0
- Page 135 and 136:
THURSDAY, NOVEMBER 11, 2010 ACR/ARH
- Page 137 and 138:
• apply these basic statistics to
- Page 139 and 140:
9:15 AM The ACR/EULAR Definition of
- Page 141 and 142:
Immunology, Oslo University Hospita
- Page 143 and 144:
9:15 AM 2239. Factors Associated wi
- Page 145 and 146:
Upon completion of this session, pa
- Page 147 and 148:
Mikkel Østergaard 6 , Paul Emery 4
- Page 149 and 150:
Ende 4 , 1 Department of Rheumatolo
- Page 151 and 152:
ACR Poster Session A Cytokines, Med
- Page 153 and 154:
ACR Poster Session A 51. Associatio
- Page 155 and 156:
ACR Poster Session A 83. Respirator
- Page 157 and 158:
ACR Poster Session A 121. Bone Dens
- Page 159 and 160:
ACR Poster Session A 142. The Intra
- Page 161 and 162:
ACR Poster Session A 171. Early Pro
- Page 163 and 164:
ACR Poster Session A Pediatric Rheu
- Page 165 and 166:
ACR Poster Session A 233. Prevalenc
- Page 167 and 168:
ACR Poster Session A 266. Subtype S
- Page 169 and 170:
ACR Poster Session A 297. Body Weig
- Page 171 and 172:
ACR Poster Session A 325. Patient R
- Page 173 and 174:
ACR Poster Session A 356. Influence
- Page 175 and 176:
ACR Poster Session A 383. Efficacy
- Page 177 and 178:
ACR Poster Session A 409. Rituximab
- Page 179 and 180:
ACR Poster Session A 441. Recombina
- Page 181 and 182:
ACR Poster Session A 465. Immunoglo
- Page 183 and 184:
ACR Poster Session A 496. IRF8 Alle
- Page 185 and 186:
ACR Poster Session A 521. DC-STAMP
- Page 187 and 188:
ACR Poster Session A 546. Prevalenc
- Page 189 and 190:
ACR Poster Session A 571. Epidemiol
- Page 191 and 192:
ACR Poster Session A 599. Validatio
- Page 193 and 194:
ACR/ARHP Poster Session B Halls B1
- Page 195 and 196:
ACR Poster Session B 767. Economic
- Page 197 and 198:
ACR/ARHP Poster Session B 792. The
- Page 199 and 200:
ACR/ARHP Poster Session B Universit
- Page 201 and 202:
ACR/ARHP Poster Session B 848. Cell
- Page 203 and 204:
ACR/ARHP Poster Session B 886. Scre
- Page 205 and 206:
ACR/ARHP Poster Session B 909. Regu
- Page 207 and 208:
ACR/ARHP Poster Session B 935. The
- Page 209 and 210:
ACR/ARHP Poster Session B 967. Frac
- Page 211 and 212:
ACR Poster Session B 993. Early Exp
- Page 213 and 214:
ACR/ARHP Poster Session B 1022. Com
- Page 215 and 216:
ACR/ARHP Poster Session B 1055. Son
- Page 217 and 218:
ACR Poster Session B 1084. Gene Exp
- Page 219 and 220:
ACR/ARHP Poster Session B 1111. Inc
- Page 221 and 222:
ACR Poster Session B hiroshima Memo
- Page 223 and 224:
ACR/ARHP Poster Session B 1166. Pre
- Page 225 and 226:
ACR/ARHP Poster Session B 1199. Typ
- Page 227 and 228: ACR/ARHP Poster Session B 1225. Phy
- Page 229 and 230: ACR/ARHP Poster Session B 1262. Lat
- Page 231 and 232: ACR/ARHP Poster Session B 1294. End
- Page 233 and 234: ACR/ARHP Poster Session B 1321. Cha
- Page 235 and 236: ACR/ARHP Poster Session C Halls B1
- Page 237 and 238: ACR/ARHP Poster Session C 1495. S10
- Page 239 and 240: ACR/ARHP Poster Session C 1524. Inc
- Page 241 and 242: ACR/ARHP Poster Session C 1555. Pro
- Page 243 and 244: ACR/ARHP Poster Session C 1583. Ass
- Page 245 and 246: ACR/ARHP Poster Session C 1596. Gen
- Page 247 and 248: ACR/ARHP Poster Session C 1622. Flu
- Page 249 and 250: ACR/ARHP Poster Session C Miscellan
- Page 251 and 252: ACR/ARHP Poster Session C L. Woodwa
- Page 253 and 254: ACR/ARHP Poster Session C 1692. Res
- Page 255 and 256: ACR/ARHP Poster Session C 1719. Los
- Page 257 and 258: ACR/ARHP Poster Session C 1749. Con
- Page 259 and 260: ACR/ARHP Poster Session C 1780. Tow
- Page 261 and 262: ACR/ARHP Poster Session C 1804. Eff
- Page 263 and 264: ACR/ARHP Poster Session C Immunolog
- Page 265 and 266: ACR/ARHP Poster Session C 2 Departm
- Page 267 and 268: ACR/ARHP Poster Session C CA, 29 Un
- Page 269 and 270: ACR/ARHP Poster Session C 1900. IL-
- Page 271 and 272: ACR/ARHP Poster Session C 1930. Cor
- Page 273 and 274: ACR/ARHP Poster Session C 1958. The
- Page 275 and 276: ACR/ARHP Poster Session C 1988. Cha
- Page 277: ACR/ARHP Poster Session C 2015. CpG
- Page 281 and 282: ACR/ARHP Poster Session C 2070. Ass
- Page 283 and 284: REF Industry Roundtable-supported S
- Page 285 and 286: REF Industry Roundtable-supported S
- Page 287 and 288: INDUSTRY-SUPPORTED POST-CONFERENCE
- Page 289 and 290: 2010 ACR/ARHP Annual Meeting Leader
- Page 291 and 292: 2010 ACR/ARHP Annual Meeting Leader
- Page 293 and 294: FLOOR PLANS 2010 Program Book 291
- Page 295 and 296: VISIT THE EXHIBIT HALL New and inno
- Page 297 and 298: EXHIBITORS La Lettre Du Rhumatologu
- Page 299 and 300: ACKNOWLEDGEMENTS The ACR, the ARHP
- Page 301 and 302: ACR/ARHP/REF STAFF LISTING Administ
- Page 303 and 304: A Ahmed, Rafi, PhD T cell Memory .
- Page 305 and 306: Cooper, Max D, MD Introduction . .
- Page 307 and 308: Gerlag, Danielle Marie, MD, PhD The
- Page 309 and 310: Physical Examination Skills for Imp
- Page 311 and 312: Meroni, Pierluigi, MD Autoantibodie
- Page 313 and 314: Rogers, Joan C, PhD, OTR/ L Underst
- Page 315 and 316: Terkeltaub, Robert, MD Crystallizin
- Page 317 and 318: A Aarden, L 1825 Aarrass, S 1519, 1
- Page 319 and 320: Bakker, AAB 1095 Barendregt, B 753
- Page 321 and 322: Boutin-Le Thi Huong, D 478 Bout-Tab
- Page 323 and 324: Chatham, WW 457, 1146, 1454, 1457,
- Page 325 and 326: Daudon, M 875 Daugas, E 2009 Davatc
- Page 327 and 328: Ehst, B 758 Eicher, JL 688 Eisen, S
- Page 329 and 330:
Gabay, OH 1484 Gaber, T 630, 1418 G
- Page 331 and 332:
Guan, M 965 Guañabens, N 975 Gudbj
- Page 333 and 334:
Homme, CL 730 Honda, E 434 Hong, JY
- Page 335 and 336:
Kambayashi, T 1354 Kamdar, AA 1160
- Page 337 and 338:
Kuller, LH 71 Kumabe, M 1164 Kumaga
- Page 339 and 340:
Looney, C 941 Looney, MR 609 Looney
- Page 341 and 342:
McCarthy, GM 1109, 1306, 1426 McCau
- Page 343 and 344:
Myouzen, K 1577 Mysiw, WJ 2096 Mysl
- Page 345 and 346:
Pans, M 1834 Parra, ER 605, 887 Ped
- Page 347 and 348:
Radka, S 1174 Radner, H 296, 1745 R
- Page 349 and 350:
Sack, KE 1898 Sacli, SF 1312 Saddic
- Page 351 and 352:
1463, 2071, 2140, 2141 Singh, K 212
- Page 353 and 354:
Takahata, M 1492 Takasaki, Y 1731 T
- Page 355 and 356:
636 van Dongen, CJJ 90 Van Doornum,
- Page 357 and 358:
Witte, T 824, 1578, 1579, 2214 Witt
- Page 359 and 360:
A α-galactosylceramide 505 A2A kno
- Page 361 and 362:
Behcet’s syndrome 1284, 1288, 129
- Page 363 and 364:
cost-utility 759, 1539 couples 1324
- Page 365 and 366:
fibroblast like synoviocyte 27 fibr
- Page 367 and 368:
impact 1063, 1325 inactive disease
- Page 369 and 370:
methylation 826, 1253, 1489 methylt
- Page 371 and 372:
233, 234, 240, 243, 252, 262, 268,
- Page 373 and 374:
1599, 1600, 1603, 1605, 1606, 1609,
- Page 375 and 376:
1226, 1227, 1229, 1230, 1231, 1233,
- Page 377 and 378:
Abelson, Abby Goulder, MD Education
- Page 379 and 380:
Massarotti, Elena M, MD Systemic Lu
- Page 381 and 382:
ACR Annual Meeting fellowS-in-train
- Page 383 and 384:
NOTES 2010 Program Book 381
- Page 385 and 386:
Enbrel ® (etanercept) Brief Summar
- Page 387 and 388:
Prescription Enbrel ® (etanercept)
Change language